Latest Bliss GVS Pharma stock price

Bliss GVS Pharma P/E Ratio

BLISSGVS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
16.62
Moderate Valuation
Moderate - Fairly valued

Current Valuation Metrics

P/E Ratio 16.62
Current Price ₹182.18
EPS (TTM) ₹8.02
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 15.33
Historical Range 8.59 - 21.47
Percentile 66.7%

Sector Context

Sector Average 57.79
Sector Median 36.22
Sector Rank #9 of 88
Sector Percentile 10.2%

Earnings Breakdown (TTM)

TTM EPS ₹10.44
Sept 2025 ₹2.58
Mar 2025 ₹1.47

Key P/E Ratio Insights for Bliss GVS Pharma

  • Trading at discount to sector average PE of 57.79

View the BLISSGVS equity price for detailed stock performance.

P/E Ratio Historical Trend for Bliss GVS Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2023 8.59 8.45 ₹72.60 NSE Low
2022 12.36 8.39 ₹103.70 NSE Low
2020 21.47 6.89 ₹147.90 NSE Moderate
2019 15.76 10.34 ₹163.00 NSE Moderate
2017 13.28 11.93 ₹158.40 NSE Low
2016 20.53 8.86 ₹181.90 NSE Moderate

Sector P/E Ratio Comparison

Comparing Bliss GVS Pharma with other companies in Healthcare sector
Sector Average
57.79
Sector Median
36.22
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate
Gennex Laboratories GENNEX 17.99 ₹329 Moderate